B
iliary epithelial cells form a protective physical barrier between liver parenchyma and the toxic compounds that are secreted in bile. The cohesion of biliary epithelial cells is maintained by apical junctional complexes (AJCs), such as tight junctions and adherens junctions. Disturbance of adherens junction integrity during development leads to defective bile duct structure that translates into cholestasis, as in the arthrogryposis, renal dysfunction, and cholestasis (ARC) syndrome. 1 Mutations in the claudin-1 gene, a gene encoding a tight junction protein, cause sclerosing cholangitis, as evidenced in the neonatal ichthyosis and sclerosing cholangitis (NISCH) syndrome. 2 In the NISCH syndrome, sclerosing cholangitis has been assigned to the increase in cellular permeability that has been evidenced in biliary epithelial cells with diminished claudin-1 expression. 3 In acquired cholestatic diseases, such as primary biliary cirrhosis, tight junctions between biliary epithelial cells are also disrupted. 4 Tight junctions control the paracellular movement of ions and solutes between cells, 5 while adherens junctions govern the physical epithelial barrier by enabling direct cell-to-cell interactions. 6 The formation of AJCs is a dynamic process regulated by transcriptional and posttranslational mechanisms. 7 As an example, the formation of adherens junctions is induced by vitamin D through the activation of PKC in keratinocytes. 8 In colon cancer cells, the transcription of E-cadherin, zonula occludens-1, claudin-1, and claudin-2 is controlled by vitamin D through the activation of the vitamin D nuclear receptor (VDR). 9, 10 Consistently, Vdr knockout mice challenged with dextran sodium sulfate display AJCs alterations leading to intestinal barrier disruption. 9 In the liver, the expression of VDR is restricted to nonparenchymal cells, such as biliary epithelial cells. 11, 12 In these cells, VDR has a direct protective function by promoting epithelial antibacterial defense that may be beneficial in cholestatic settings. 11 Moreover, extrahepatic signals triggered by the vitamin D-VDR axis may also protect hepatocytes from cholestatic injuries by controlling the expression of genes involved in bile acid metabolism and transport. 13, 14 The potential involvement of VDR in cholestatic diseases is highlighted by the association of VDR polymorphisms with increased susceptibility to primary biliary cirrhosis. 15 Therefore, we tested the hypothesis that VDR may protect the liver from biliary-type hepatic injury by controlling AJCs.
Materials and Methods
Animals. Vdr 2/1 heterozygous mice (B6.129S4-Vdr tm1Mbd /J) were obtained from Charles River Laboratories (Wilmington, MA). 16 Vdr 2/2 knockout and Vdr 1/1 wildtype mice were generated by heterozygous breeding. Animals were housed in a conventional facility and had free access to water. Mineral ion levels were normalized in Vdr 2/2 mice by feeding a rescue diet (TD96348, Harlan Laboratories, Indianapolis, IN) containing 2% calcium, 1.25% phosphorus, 20% lactose, and 2.2 IU vitamin D/g from weaning.
17 C57BL/ 6J wildtype mice (Janvier Europe, St Berthevin, France) were fed either a regular chow diet or the rescue diet from weaning. All experiments were performed according to national guidelines for the care and use of laboratory animals and protocols were approved by the Ethics Committee in Animal Experiment Charles Darwin of UPMC (Approval number: Ce5/2010/024).
Animal Surgery. Experiments were performed using Vdr 2/2 mice, wildtype littermates, or C57BL/6J wildtype mice at 8 to 10 weeks of age. Biliary-type liver injury was performed under isoflurane anesthesia by double ligation and section of the common bile duct (BDL). Sham-operated mice underwent laparotomy with exposure of the common bile duct, without ligation. A group of C57BL/6J wildtype mice under regular chow diet was injected intraperitoneally with 1a-hydroxyvitamin D 3 (1a(OH)D 3 ; 31 nmol/kg) or vehicle (olive oil) 1 day before and 1 and 2 days after surgery, as described. 13 Three days after surgery, liver of all mice was collected under isoflurane anesthesia and blood was withdrawn from the vena cava. Liver samples were fixed in 4% formalin and embedded in paraffin for histology. Aliquots of the liver were embedded in TissueTek O.C.T. Compound (Electron Microscopy Sciences, Hatfield, PA) for cryosections, or snap-frozen in liquid nitrogen and stored at 280 C for RNA, protein, and bile acid analyses. Cell Culture and Transient Transfection. The human biliary epithelial cell line Mz-ChA-1 18 was cultured in Dulbecco's modified Eagle's medium (DMEM), supplemented with 1 g/L glucose, 10 mmol/L Hepes, and 10% fetal bovine serum (FBS), under 95% air and 5% CO 2 at 37 C. The culture medium was renewed every 48 hours. For transient transfection experiments, Mz-ChA-1 cells were seeded into 12-well plates (100,000 cells/well). Cells were transfected using Lipofectamine 2000 (Life Technologies, Carlsbad, CA) with either human VDR, Calpain 1, or epidermal growth factor receptor (EGFR) ON-TARGETplus SMART pools small interfering RNA (siRNA), or with a nontargeting siRNA (Thermo Scientific, Waltham, MA). Six hours after transfection, cells were transferred overnight to serum-free medium and were maintained in culture for a total of 72 hours after transfection. For investigations of the EGFR pathway, Mz-ChA-1 cells were incubated in serum-free medium for 24 hours before starting the experiments and then treated with EGF (50 ng/mL; PeproTech, Rocky Hill, NJ) for 5 minutes to 48 hours. In some experiments, cells were preincubated with an EGFR inhibitor, AG1478 (10 lM; Calbiochem, Merck, Darmstadt, Germany).
Biochemistry and Bile Acid Measurement. Plasma concentrations of bile acids, aspartate, and alanine aminotransferases were determined with a Beckman Coulter AU640 analyzer. Bile acid pool composition and tetrahydroxylated bile acids were measured in the liver by high-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS) as described. 19 Histology, Immunohistochemistry, and Immunocytology. For histology, sections (5 lm) of formalinfixed, paraffin-embedded liver tissue were stained with hemalun, phloxin, safran (HPS) or Sirius red. For immunohistochemistry, cryosections of liver tissue were fixed in 4% paraformaldehyde for 10 minutes at room temperature. Briefly, sections were permeabilized and blocked in 0.02% Surfact-Amps X100 (Thermo Scientific) with 100 mM glycine and 1% albumin for 1 hour at room temperature. Sections were then incubated overnight at 4 C with a primary antibody against E-cadherin. Secondary antibody was a Cyanine 3 (Cy3)-conjugated goat anti-rat antibody (dilution 1:100; Life Technologies) and DAPI was used for nuclei staining (Sigma Aldrich, St. Louis, MO). Liver tissue section immunostained for E-cadherin were then analyzed by an investigator unaware of the mouse genotype (D.F.). Typical bile ducts displayed membranous E-cadherin expression between biliary epithelial cells. Bile ducts were considered as ruptured when E-cadherin staining was absent between at least two adjacent biliary epithelial cells. For immunocytology, Mz-ChA-1 cells were grown on glass, fixed with 4% paraformaldehyde for 15 minutes, permeabilized and blocked in 0.02% Surfact-Amps X100 (Thermo Scientific) with 1% albumin and 10% goat serum for 1 hour at room temperature. Cells were then incubated overnight at 4 C with a primary antibody against E-cadherin. Primary antibody was revealed by an Alexa Fluor 488-conjugated goat anti-mouse secondary antibody (dilution 1:200; Life Technologies) and DAPI was used for nuclei staining. All antibodies used for immunodetection are listed in Supporting Table 1 .
Immunoblot. Liver samples and Mz-ChA-1 cells were either disrupted with tungsten carbide beads and a TissueLyser apparatus (Qiagen, Hilden, Germany) or directly lysed in RIPA buffer, respectively. RIPA lysis buffer was composed of 50 mmol/L Tris-HCl (pH 7.5), 450 mmol/L NaCl, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 1% NP-40, and supplemented with 1 mM orthovanadate and a protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN). After centrifugation for 15 minutes at 4 C, supernatants were collected and protein concentration was determined using the BCA Protein Assay (Thermo Scientific). Equal amounts of proteins were resolved by 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then processed for conventional western blot, using 0.2 lm nitrocellulose membranes and the antibodies listed in Supporting Table 1 .
Quantitative Polymerase Chain Reaction (qPCR). Total RNA was extracted from liver samples using TissueLyser apparatus and RNeasy Mini Kit (Qiagen). Complementary DNA was synthesized from 1 lg of total RNA using random hexamer primers and 200 U of Moloney murine leukemia virus reverse transcriptase (Life Technologies) for 1 hour at 37 C. qPCR was performed using the Platinum SYBR Green qPCR SuperMix-UDG (Life Technologies) on a LightCycler 1.5 (Roche Diagnostics, Basel, Switzerland). Sequences of primers used in qPCR are listed in Supporting Table 2 . Results are reported relative to a calibrator according to the 2 -DDCt method with glyceraldehyde-3-phosphate dehydrogenase (Gapdh) used as the reference gene.
Protein Identification by Mass Spectrometry. . Whole liver protein extracts were immunoprecipitated with an antibody directed against E-cadherin (Supporting Table 1 ). Precipitated proteins were submitted to SDS-PAGE, silver stained, and extracted from gel before mass spectrometry analysis, as described in the Supporting Material.
Statistical Analysis. Comparisons were made using Student t test. P < 0.05 was considered significant.
Results

BDL-Induced Liver Injury Is Exacerbated in Vdr
2/2 Mice. Vdr 2/2 mice displayed more hepatic damage than wildtype mice at histological examination of the liver 3 days after BDL (Fig. 1A) . Accordingly, aminotransaminase activities were higher in Vdr 2/2 mice compared to control mice (Fig. 1B) . Plasma bile acid levels were increased four times more in Vdr 2/2 mice than in wildtype mice after BDL (Fig. 1C) . These observations indicate that Vdr 2/2 mice display more severe hepatic injury after biliary-type liver disease. To ascertain the potential protective role of VDR activation, wildtype mice submitted to BDL were injected with 1a(OH)D 3 , as described. 13 Aminotransaminase activities and bile acid plasma levels were not significantly modified by exposure to 1a(OH)D 3 (Supporting Fig. 1 ). Taken together, these results indicate that the absence of VDR is a susceptibility factor to biliary-type liver injury. Vdr 2/2 Mice Are Unable to Develop Adaptive Response. The extent of hepatic damage following biliary-type liver injury is limited by adaptive changes in bile acid metabolism and transport. 20 The expression of cholesterol 7-alpha-hydroxylase (Cyp7a1) and sterol 12-alpha-hydroxylase (Cyp8b1) messenger RNA (mRNA) was decreased to a similar extent in both genotypes after BDL (Supporting Fig. 2) . Consistently, the bile acid pool composition was similar in Vdr 2/2 and wildtype BDL mice (Supporting Fig. 3 ). Transcript levels of Na 1 -taurocholate cotransporting polypeptide (Ntcp) were also similarly decreased in both genotypes after BDL (Supporting Fig. 2 ). By contrast, the expression of the bile salt export pump (Bsep) and the phospholipid flippase (Mdr2), which is increased in cholestatic settings, 21 was unchanged in Vdr 2/2 mice after BDL ( Fig.  2A,B) . Expression of the multidrug resistance-associated protein 3 (Mrp3) mRNA was induced in both genotypes after BDL, but this increase was less prominent in Vdr 2/2 mice (Fig. 2C) . Finally, the expression of cytochrome P450 3a11 (Cyp3a11) mRNA increased in wildtype but not in Vdr 2/2 mice after BDL (Fig. 2D ). The absence of Cyp3a11-mediated response in Vdr 2/2 mice was confirmed by the lack of a significant increase in hepatic tetrahydroxylated bile acids after BDL (Fig.  2E) . 22 Functional loss of liver parenchyma and of bile ducts during biliary-type liver injury is limited by tissue scarring and ductular reaction, respectively. 23, 24 Accordingly, liver of mice from both genotypes presented slight collagen deposits in the periportal area 3 days post-BDL. No difference, however, was evident between Vdr 2/2 mice and control littermates based on Sirius red staining (Fig. 3A) . At mRNA levels, the expression of Tgf-b, a-Sma and type I collagen (Col1a1) was significantly increased in wildtype mice, but was not modified in Vdr 2/2 mice after BDL (Fig. 3B-D) . Furthermore, histological examination of the liver suggested that Vdr 2/2 mice developed less ductular reaction than wildtype mice in response to BDL (Fig. 3E) . This result was supported by the analysis of cytokeratin 19 (Ck19) mRNA expression, which was significantly increased after BDL in wildtype animals but not in Vdr 2/2 mice (Fig. 3F) 25, 26 Because VDR controls AJCs in other epithelia, 9, 10 we assessed hepatic E-cadherin expression by immunostaining in Vdr 2/2 and wildtype mice. In sham-operated mice of both genotypes, E-cadherin expression was evident at the membrane of biliary epithelial cells. After BDL, biliary epithelial cells displayed an altered staining pattern of E-cadherin, corresponding to bile duct disruption. Ruptured bile ducts were two times more frequent in Vdr 2/2 mice than in wildtype mice (Fig. 4A) . These results suggest that alteration of adherens junctions leads to AJCs defects in the biliary epithelial cells of Vdr 2/2 mice submitted to biliary-type liver injury. Moreover, these observations suggest that the increased liver injury observed in these mice is related to the disruption of cell-cell interactions between biliary epithelial cells. E-cadherin protein content in whole liver, however, was not significantly different between wildtype and Vdr 2/2 mice after BDL. Yet Vdr 2/2 mice were characterized by a marked increase in the expression of a lower weight E-cadherin signal after BDL (Fig. 4B) . Analysis of this 100-kDa protein signal by mass spectrometry indicated that it corresponded to a truncated form of E-cadherin that was previously described to promote cellular dissociation (Fig. 4C) . 27 These results therefore suggest that the bile duct rupture observed in Vdr 2/2 mice is related to a loss of adherens junctions in biliary epithelial cells caused by E-cadherin truncation.
VDR Silencing Leads to E-cadherin Cleavage in Biliary Epithelial Cells. To investigate the impact of VDR on E-cadherin cleavage in biliary epithelial cells, we down-regulated VDR by siRNA in a biliary epithelial cell line. As shown in Fig. 5A , E-cadherin cleavage occurred in cells with diminished VDR expression. Furthermore, diminished VDR expression in biliary epithelial cells was associated with both the loss of regular E-cadherin membrane staining and the disruption of cell-cell contacts (Fig. 5B) . Because the 100-kDa truncated form of E-cadherin has been shown to result from a calpain-mediated cleavage, 28 we analyzed the effect of VDR down-regulation on calpain activation. A 75-kDa autocleaved fragment specific for calpain 1 activation was detected in biliary epithelial cells with diminished VDR expression, 29 while no modification 2/2 mice 3 days post-BDL and were assessed for E-cadherin expression by immunoblot. b-Actin was used as an internal control. (C) Whole liver protein extracts were immunoprecipitated with an antibody directed against E-cadherin. After gel migration, the 100-kDa protein signal was extracted and submitted to mass spectrometry analysis. The full E-cadherin protein sequence is shown, with dark boxes representing the peptides identified by mass spectrometry. The underlined sequence corresponds to the calpain cleavage site consensus sequence.
was found for calpain 2 (Fig. 5A) . In biliary epithelial cells that were down-regulated for both VDR and calpain 1, no induction of E-cadherin cleavage could be observed, indicating that the E-cadherin cleavage observed in VDR-deficient cells is mediated by calpain 1 (Fig. 5C) .
VDR Down-Regulation Activates Calpain 1 Through the EGFR Signaling Pathway in Biliary Epithelial Cells. Calpain activation may be triggered by the EGFR pathway in fibroblasts. 30 Thus, we tested the potential of EGF to induce calpain 1 activation and E-cadherin cleavage in biliary epithelial cells. Timecourse analysis showed that EGF induced calpain 1 activation, which preceded E-cadherin truncation (Fig. 6A) . Consistently, biliary epithelial cells lost their cell-to-cell contacts, while E-cadherin staining became mainly intracellular (Fig. 6B) . The effect of EGF on calpain 1 activation and subsequent E-cadherin truncation was abrogated when EGFR expression was diminished by siRNA (Fig. 6C) . Furthermore, pharmacological inhibition of EGFR signaling by AG1478 maintained adherens junctions integrity in biliary epithelial cells treated with EGF (Fig. 6D) . In biliary epithelial cells silenced for calpain 1, EGF was unable to induce E-cadherin cleavage (Fig. 6E) . Thus, these results demonstrate that the EGFR pathway triggers calpain 1 activation, resulting in E-cadherin cleavage in biliary epithelial cells. Because the vitamin D-VDR axis has been shown to negatively regulate the EGFR pathway, 31, 32 we next analyzed the activation status of the EGFR pathway in VDR-silenced cells. EGFR signaling was increased in cells with diminished VDR expression as ascertained by higher EGFR, phosphorylated EGFR, and phosphorylated ERK protein levels (Fig. 7A) . In biliary epithelial cells down-regulated for both VDR and EGFR, calpain 1 activation and E-cadherin cleavage were blunted when compared to VDR-silenced cells (Fig. 7B) . These findings therefore indicate that downregulation of VDR triggers the EGFR signaling pathway, resulting in calpain 1-activation and subsequent E-cadherin cleavage. 
Discussion
In this study we show that loss of VDR exacerbates biliary-type liver injury. The hypothesis that VDR has a broad protective role in biliary-type liver injury was raised following our previous observation that VDR protects biliary epithelial cells by inducing innate defenses. 11 In addition, the vitamin D-VDR axis has been shown to control genes involved in bile acid metabolism and transport, the regulation of which is crucial to protect the liver from cholestatic injury. 13, 14 However, VDR activation by acute vitamin D exposure did not provide protection towards BDL. Yet a chronic increase in vitamin D intake by means of rescue diet feeding led to a reduction in hepatic damage in wildtype mice submitted to BDL (Supporting Fig. 4) . Because the rescue diet is also enriched in calcium, phosphorus, and lactose, the detailed molecular and cellular mechanisms triggering such a protective effect remain unknown. According to our observations, we can only speculate that the chronic intake of an increased exogenous vitamin D dose protects the liver from biliary injury. Taken together, our observations indicate that the absence of VDR is accountable for the observed susceptibility towards biliary-type liver injury.
The extent of injury following toxic bile accumulation in the liver parenchyma is counterbalanced by adaptive mechanisms. 26 Vdr 2/2 mice were unable to efficiently adapt to biliary-type liver injury by modifying hepatocellular gene expression when compared to wildtype mice. Because VDR expression is absent from hepatocytes, 11, 12 the observation of a defective adaptation to cholestasis suggests that the triggering signals originate from non-parenchymal liver cells or extra-hepatic cells. 13, 14 Furthermore, only wildtype mice displayed a significant ductular proliferation assessed by increased Ck19 mRNA levels. Proliferating biliary epithelial cells have signaling activities towards hepatocytes, 33 thus lack of ductular reaction in Vdr 2/2 mice may directly impact liver adaptive mechanisms to BDL. Moreover, ductular reaction may represent an evacuation route for bile in cholestatic settings. 34 Thus, the absence of significant ductular reaction may increase toxic accumulation in Vdr 2/2 mice. These observations suggest that VDR has an indirect effect on hepatocytes that is required for the liver to adapt to biliary-type hepatic injury.
The release of toxic bile in liver parenchyma is directly related to the ability of biliary epithelial cells to maintain sealed ducts. Because VDR has been shown to control AJCs in other epithelia, 9,10 we analyzed E-cadherin staining in mice submitted to BDL. Vdr 2/2 mice displayed more bile duct ruptures that paralleled defective E-cadherin staining, suggesting that VDR is required in biliary epithelial cells to ensure cell-cell interactions. The absence of VDR led to a strong increase in plasma bile acids and aminotransferases after BDL, further suggesting extensive bile spillover and subsequent increased hepatic toxicity. While no significant change could be observed in E-cadherin protein expression, we showed that a truncated form of E-cadherin was increased in Vdr 2/2 mice submitted to BDL. This truncated form of E-cadherin has been shown to induce epithelial cell dissociation, 27 suggesting that the cleavage of E-cadherin leads to bile duct rupture. Moreover, we have shown that E-cadherin cleavage results from calpain 1-activation, as evidenced in biliary epithelial cells invalidated for VDR. The truncated form of E-cadherin was detected by immunoblot in whole liver lysates, suggesting that E-cadherin cleavage also occurs in hepatocytes. Calpain activation in hepatocytes may result from the release of activated calpain from biliary epithelial cells. Indeed, autoactivation of calpains was previously described as a self-perpetrating injury mechanism in the liver of rats submitted to chemical intoxication. 35 Thus, our observations suggest that calpain activation and subsequent E-cadherin cleavage triggered by the absence of VDR leads to enhanced liver injury.
The EGFR pathway controls calpain 2-activation through ERK in fibroblasts. 30 Herein, we show that EGF activates calpain 1 in biliary epithelial cells. Consistent with the observation that the vitamin D-VDR axis downregulates EGFR expression, 31, 32 we demonstrate that invalidation of VDR in biliary epithelial cells results in EGFR pathway activation. Furthermore, the cleavage of E-cadherin is not observed in biliary epithelial cells silenced for both VDR and EGFR. Taken together, these results indicate that loss of VDR controls E-cadherin cleavage in biliary epithelial cells by activating calpain 1 through the EGFR signaling pathway.
VDR gene polymorphisms have been associated with inflammatory bowel disease (IBD), 36 ,37 a condition commonly associated with primary sclerosing cholangitis (PSC). 38 Increased intestinal permeability, a feature of IBD, may result from AJCs perturbations as evidenced in Vdr 2/2 mice submitted to dextran sodium sulfate. 9 Intestinal permeability by allowing bacterial products to be released in the general circulation may aggravate PSC. First, bacterial products have been shown to exacerbate the immune attack against biliary epithelial cells. 39 Second, endotoxins can trigger fibrosis by stimulating dedicated receptors on nonparenchymal liver cells. 40 Accordingly, our data indicate that sham-operated Vdr 2/2 mice have an increased expression of profibrotic genes (i.e., a-Sma and Col1a1) compared to sham-operated wildtype mice. Finally, endotoxins may directly favor the disruption of biliary epithelial cell AJCs, 41 a feature that has been documented in a mouse model of PSC. 42 Thus, the vitamin D/VDR axis may be involved in the phenotypic features of PSC by both an indirect effect on intestinal permeability and a direct effect on nonparenchymal liver cells.
In conclusion, our data suggest that loss of VDR sensitizes the liver to biliary-type hepatic injury. VDR may be involved in such a process by controlling biliary epithelial cell innate immunity, through the induction of antibacterial defense 11 and by ensuring epithelial cohesion, as demonstrated herein. The respective involvement in biliary diseases of VDR expressed in nonparenchymal liver cells or cells of extrahepatic origin remains, however, to be fully determined.
